Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,461 studies match

clinicaltrialsPublishedShowing 701–750 of 2,461 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03822117	Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)	terminated	Phase 2	111	Incyte CorporationINDUSTRY	11	Nov 4, 2025	clinicaltrials
NCT04003610	Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)	terminated	Phase 2	7	Incyte CorporationINDUSTRY	16	Nov 4, 2025